It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Chronic disease is endemic and epidemic in the world. For example, the top 5 chronic diseases - heart disease, cancer, stroke, COPD, and diabetes - cause more than two-thirds of all deaths in the USA. More than 90 million Americans are estimated to have chronic disease.
Byrd said:For those of you not familiar with the science process, it's perfectly legit to have conferences on tightly focused topics. But when you use emotionally loaded words like "disease mongering" then what you're going to get is people who need publication credits who are crafting papers to prove your point.
Grrrrrrrrrrrrrrrr................
Quote, sofiFYI - "restless leg" for example is a common symptom of extremely high blood pressure. High blood pressure leads to strokes.
Originally posted by DontTreadOnMe
And, like the poster above, shouldn't people take some responsibility for their lifestyle, eat better, exercise, etc. and not expect pills to do it all?
Originally posted by marg6043
That's the sad thing nobody in this day and times wants to take responsibility for their own health problems and every day problems, because after all is a magic pill already waiting or in the making to take care of the Symptoms.
But. . . Has any body said cure?
But not a single propaganda commercial that I have see so far said We are finding cures so you don't have to depend of remedies and medications for the rest of your life..
FDA Approves Botox to Treat Severe Underarm Sweating
FDA has approved Botulinum Toxin Type A (Botox) to treat severe underarm sweating known as “primary axillary hyperhidrosis” that cannot be managed by topical agents such as prescription antiperspirants. Botox has already been approved for several other purposes. Today’s approval allows the product’s manufacturer, Allergan, Inc., Irvine, Calif., to market Botulinum Toxin Type A for this new indication.
more